Many organizations take a siloed approach to 340B. If you’re treating your 340 Program as strictly a pharmacy program, you’re probably missing out on savings. The reality is that 340B performance is inextricably linked to other areas of operations. Operational workflows, financial reporting, and human resources procedures can profoundly impact 340B savings. Ravin Consultants has outlined several “operational hacks” that Covered Entities can deploy, today, to maximize their 340B savings.

A variety of activity and attention continues to surround the 340B Drug Pricing Program and its key stakeholders. This webinar series, now in its 4th iteration, examines the most pressing issues impacting those directly involved with 340B efforts at their organization. Continue the conversation for and between covered entities and manufacturers with insight around the potential legislative, regulatory, judicial, and business activities affecting the program, including the continuing dispute around contract pharmacy arrangements, and best practices for covered entities to ensure program integrity and compliance and maximize savings.

Join us for the webinar "340B Primer: Learn the Basics of the 340B Program" (perfect for newcomers). Please also join us on December 12 at 2pm for an educational seminar "Discriminatory Reimbursement: How to Kick-Start State Advocacy Efforts." Learn more at https://www.rwc340b.org/webinars/ or contact Andrea.Jeria@PowersLaw.com.

Join us for the webinar "Discriminatory Reimbursement: How to Kick-Start State Advocacy Efforts." Learn more at https://www.rwc340b.org/webinars/ or contact Andrea.Jeria@PowersLaw.com.